Hinge Health, Inc. is trading 5.2% up today at $66.23, extending a sharp multi-day rally after announcing a $250 million share repurchase program and drawing strong bullish analyst coverage.
- Needham recently named the stock a top health tech pick for 2026, while Truist reiterated a Buy rating, citing recent earnings strength and positive momentum.
- The stock continues to see significant upside and is outperforming the broader market despite general market weakness.